Patents by Inventor Jean-Yves Marcel Paul Bonnefoy

Jean-Yves Marcel Paul Bonnefoy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies to CD23, derivatives thereof, and their therapeutic uses
    Patent number: 7008623
    Abstract: The invention relates to antibodies which bind to the CD23 (FC?RII) type II molecule particularly altered antibodies including antibodies which bind to the CD23 (FC?RII) type II molecule characterized by an affinity constant equal to or greater than 1×109 Ka Mol?1, the preparation of such antibodies, pharmaceutical compositions which contain such antibodies and their use in therapy particularly in the treatment of autoimmune and inflammatory disorders.
    Type: Grant
    Filed: May 7, 1999
    Date of Patent: March 7, 2006
    Assignee: Glaxo Wellcome Inc.
    Inventors: Jean-Yves Marcel Paul Bonnefoy, James Scott Crowe, Jonathan Henry Ellis, Nicholas Timothy Rapson, Jean Shearin
  • Binding agents to CD23
    Publication number: 20040022783
    Abstract: The present invention relates to agents that bind CD23 and that can be used in the treatment of inflammatory, autoimmune or allergic diseases.
    Type: Application
    Filed: August 4, 2003
    Publication date: February 5, 2004
    Applicant: SMITHKLINE BEECHAM CORPORATION
    Inventor: Jean-Yves Marcel Paul Bonnefoy